Abstract
Tuberculosis, caused by the organism Mycobacterium tuberculosis, is one of the major public health threats in the world. The emergence of multidrug resistant strains poses serious threats to the control of this disease due to the complex nature of second-line drug treatment. Upon infection, the bacterium goes through an initial replication phase after which it enters a nonreplicative, drug-resistant state of dormancy. The bacterium is able to survive in this dormant state for decades until the hosts immune system is weakened when it reactivates and causes the infectious disease.
Document Type
Patent
Patent Number
US 7,601,357
Application Serial Number
11/561,460
Issue Date
10-13-2009
Current Assignee
UCFRF
Assignee at Issuance
UCFRF
College
Burnett School of Biomedical Sciences
Department
Biomolecular Science Center
Allowance Date
6-5-2009
Filing Date
11-20-2006
Assignee at Filing
UCFRF
Filing Type
Nonprovisional Application Record
Donated
no
Recommended Citation
Kolattukudy, Pappachan; Daniel, Jaiyanth; and Deb, Chirajyoti, "Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment" (2009). UCF Patents. 585.
https://stars.library.ucf.edu/patents/585